• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超中心型肺肿瘤立体定向体部放射治疗的最新进展与当前挑战

Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors.

作者信息

Salvestrini Viola, Lastrucci Andrea, Banini Marco, Loi Mauro, Carnevale Maria Grazia, Olmetto Emanuela, Garlatti Pietro, Simontacchi Gabriele, Francolini Giulio, Bonomo Pierluigi, Wandael Yannick, Desideri Isacco, Ricci Renzo, Giansanti Daniele, Scotti Vieri, Livi Lorenzo

机构信息

Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.

Department of Allied Health Professions, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.

出版信息

Cancers (Basel). 2024 Dec 11;16(24):4135. doi: 10.3390/cancers16244135.

DOI:10.3390/cancers16244135
PMID:39766035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11674056/
Abstract

Stereotactic body radiotherapy has been established as a viable treatment option for inoperable early-stage non-small cell lung cancer or secondary lesions mainly in oligoprogressive/oligometastatic scenarios. Treating lesions in the so-called "no flight zone" has always been challenging and conflicting data never cleared how to safely treat these lesions. This is truer considering ultra-central lesions, i.e., directly abutting or whose PTV is overlapping critical mediastinal organs. While historical retrospective data are abundant but mostly heterogenous in terms of the definition of ultra-central lesions, dosing regimens and outcomes, prospective data remain scarce, even though recently published studies have given new encouraging results for such delicate treatment scenarios. For this reason, we aimed to review and summarize current knowledge on stereotactic radiation treatment for ultra-central thoracic lesions, highlighting the most recent advances and the messages that can be taken from them. Lastly, we propose a workflow of the necessary steps to identify and treat such patients, therefore helping in elucidating the advantages and caveats of such treatment options.

摘要

立体定向体部放疗已被确立为不可手术的早期非小细胞肺癌或主要在寡进展/寡转移情况下的继发性病变的一种可行治疗选择。在所谓的“禁区”治疗病变一直具有挑战性,相互矛盾的数据从未明确如何安全地治疗这些病变。考虑到超中央病变,即直接毗邻或其计划靶体积与关键纵隔器官重叠的病变,情况更是如此。虽然历史回顾性数据丰富,但在超中央病变的定义、给药方案和结果方面大多存在异质性,前瞻性数据仍然稀缺,尽管最近发表的研究为这种精细的治疗情况给出了新的令人鼓舞的结果。出于这个原因,我们旨在回顾和总结当前关于超中央胸部病变立体定向放射治疗的知识,突出最新进展以及从中可以获得的信息。最后,我们提出了识别和治疗此类患者的必要步骤的工作流程,从而有助于阐明此类治疗选择的优势和注意事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb19/11674056/2fc33f6e56b5/cancers-16-04135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb19/11674056/0f168b21f1ae/cancers-16-04135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb19/11674056/2fc33f6e56b5/cancers-16-04135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb19/11674056/0f168b21f1ae/cancers-16-04135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb19/11674056/2fc33f6e56b5/cancers-16-04135-g002.jpg

相似文献

1
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors.超中心型肺肿瘤立体定向体部放射治疗的最新进展与当前挑战
Cancers (Basel). 2024 Dec 11;16(24):4135. doi: 10.3390/cancers16244135.
2
Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.立体定向体部放射治疗(SBRT)用于寡复发/寡进展性纵隔和肺门淋巴结转移:一项系统评价
Cancers (Basel). 2022 May 28;14(11):2680. doi: 10.3390/cancers14112680.
3
Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART).采用立体定向磁共振引导自适应放疗(SMART)拓宽中轴和超中轴寡转移瘤的治疗窗口。
Radiother Oncol. 2024 Jan;190:110034. doi: 10.1016/j.radonc.2023.110034. Epub 2023 Nov 27.
4
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy.超中心型肺部肿瘤:长时间立体定向体部放疗的安全性和有效性。
Acta Oncol. 2021 Aug;60(8):1061-1068. doi: 10.1080/0284186X.2021.1942545. Epub 2021 Jun 30.
5
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.立体定向体部放疗治疗超中心型肺部肿瘤:系统评价和荟萃分析以及国际立体定向放射外科协会实践指南。
Lung Cancer. 2023 Aug;182:107281. doi: 10.1016/j.lungcan.2023.107281. Epub 2023 Jun 21.
6
Stereotactic body radiation therapy in the management of lung neoplasms: is it ready for prime time?立体定向体部放射治疗在肺癌治疗中的应用:它已准备好成为主流治疗方法了吗?
Curr Opin Pulm Med. 2025 Jul 1;31(4):326-334. doi: 10.1097/MCP.0000000000001171. Epub 2025 Apr 23.
7
Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions.立体定向体部放射治疗用于肺部、脊柱及寡转移疾病:当前证据与未来方向
Ann Transl Med. 2018 Jul;6(14):283. doi: 10.21037/atm.2018.06.40.
8
The analysis of the efficacy and safety of stereotactic body radiotherapy with sequential immune checkpoint inhibitors in the management of oligoprogressive advanced non-small cell lung cancer.立体定向体部放疗联合序贯免疫检查点抑制剂治疗寡进展期晚期非小细胞肺癌的疗效和安全性分析
Transl Cancer Res. 2024 May 31;13(5):2408-2418. doi: 10.21037/tcr-23-2232. Epub 2024 May 7.
9
Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.寡进展性非小细胞肺癌的加速适形磁共振引导自适应放疗。
Med Dosim. 2023;48(4):238-244. doi: 10.1016/j.meddos.2023.05.002. Epub 2023 Jun 15.
10
Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.风险适应性立体定向体部放射治疗中、超中心早期不可手术非小细胞肺癌。
Cancer Sci. 2019 Nov;110(11):3553-3564. doi: 10.1111/cas.14185. Epub 2019 Sep 9.

本文引用的文献

1
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.立体定向放疗与低分割放疗治疗不可手术的 I 期非小细胞肺癌:LUSTRE Ⅲ期随机临床试验。
JAMA Oncol. 2024 Nov;10(11):1571-1575. doi: 10.1001/jamaoncol.2024.3089. Epub 2024 Sep 19.
2
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results.立体定向体部放疗治疗不可手术的中央型早期非小细胞肺癌:EORTC 22113-08113 LungTech Ⅱ期临床试验结果。
J Thorac Oncol. 2024 Sep;19(9):1297-1309. doi: 10.1016/j.jtho.2024.05.366. Epub 2024 May 22.
3
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions.
超中央型肺部病变的立体定向MRI引导下适形放射治疗中结构特异性刚性剂量累积剂量学分析
Commun Med (Lond). 2024 May 22;4(1):96. doi: 10.1038/s43856-024-00526-7.
4
Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumor.适形调强立体定向体部放射治疗超中央型肺肿瘤的安全性与有效性
Medicina (Kaunas). 2024 Mar 26;60(4):538. doi: 10.3390/medicina60040538.
5
Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.立体定向体部放射治疗超中心型胸内肿瘤的安全性和疗效:单中心回顾性研究。
Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):359-369. doi: 10.1016/j.ijrobp.2024.04.009. Epub 2024 Apr 14.
6
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).立体定向放疗治疗超中心型非小细胞肺癌的安全性和有效性试验(SUNSET)。
Int J Radiat Oncol Biol Phys. 2024 Nov 1;120(3):669-677. doi: 10.1016/j.ijrobp.2024.03.050. Epub 2024 Apr 12.
7
Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART).采用立体定向磁共振引导自适应放疗(SMART)拓宽中轴和超中轴寡转移瘤的治疗窗口。
Radiother Oncol. 2024 Jan;190:110034. doi: 10.1016/j.radonc.2023.110034. Epub 2023 Nov 27.
8
SGRT-based stereotactic body radiotherapy for lung cancer setup accuracy and margin of the PTV.基于体表图像引导放疗的立体定向体部放疗用于肺癌的摆位精度和计划靶区边界
J Appl Clin Med Phys. 2024 Mar;25(3):e14195. doi: 10.1002/acm2.14195. Epub 2023 Nov 1.
9
Sinoatrial Node Dose Is Associated With Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Cancers.接受根治性立体定向体部放射治疗的中央型肺癌患者,窦房结剂量与生存预后更差相关。
Pract Radiat Oncol. 2024 Jan-Feb;14(1):e40-e47. doi: 10.1016/j.prro.2023.09.005. Epub 2023 Oct 5.
10
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT.立体定向体部放疗治疗的超中心型肺肿瘤患者17个心脏亚结构的剂量学分析、毒性反应及生存情况
Clin Transl Radiat Oncol. 2023 Sep 13;43:100675. doi: 10.1016/j.ctro.2023.100675. eCollection 2023 Nov.